期刊文献+

多功能模块合成心肌显像剂^(18)F-FTHA及Micro-PET显像 被引量:3

Labeling and Imaging Study of Fatty Acid Analogue ^(18)F-FHTA on Domestic Synthesis Module
下载PDF
导出
摘要 用国产氟多功能模块合成心肌脂肪酸代谢显像剂18 F-FTHA用于临床研究。以苄基-14-(R,S)-对甲苯磺酰基-6-硫代十七烷酸酯为前体,在氟多功能模块上经亲核反应、水解及HPLC纯化,最后经固相萃取,得到18 F-FTHA。研究其在正常NH小鼠体内的生物学分布以及正常SD大鼠Micro-PET显像。结果显示,18F-FTHA不校正合成效率为10.6%,合成时间为50min。18F-FTHA的放化纯度为99%,体外稳定性良好。生物学分布结果表明,60min心肌摄取为19.04ID%/g;心与肝放射性摄取比在60~90min达到3~6倍;Micro-PET心肌显像清晰。结果提示,国产氟多功能模块合成18F-FTHA耗时短,放化纯度高,其质量符合氟-18药物的临床。 18F-6-thia-14-fluoro-heptadecanoic acid (ISF-FTHA), a free fatty acid, has been used in myocardial PET imaging. In order to establish an automated synthesis module for routine production, a study was performed on domestic synthesis module. Methods: 18F- FTHA was prepared from Benzyl-14-tosyloxy-6-thia-heptadecanoate as precursor. Biodistri- bution studies in the NH rats and Micro-PET/CT imaging studies in the SD rat were per- formed. The results showed that total synthesis time was about 50 minutes and the uncor- rected synthesis yield was 10.6%, radiochemical purity was higher than 99%, the product had good stability at room temperature. Biodistribution data in rats showed the uptake of heart was 19.04 ID%/g at 60 minutes, heart-to-liver ratios at 60 and 90 min were 6.4 and 3.2, respectively. Micro PET/CT imaging of the SD rat showed intense cardiac uptake.Conclusions. Using this procedure a fast, reliable, automated synthesis for the myocardial PET tracer, 18F-FTHA, can be obtained.
出处 《同位素》 CAS 2013年第4期222-227,共6页 Journal of Isotopes
关键词 18F-FTHA 脂肪酸 国产多功能模块 18F-FTHA fatty acids domestic synthesis module
  • 相关文献

参考文献17

  • 1Mittendorfer B, Liem O. What does the measure ment of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean[J]. Diabetes, 2003, 52:1 641-1 648.
  • 2Aarsland A, Chinkes D, Wolfe RR. Contributions of de novo synthesis of fatty acids to total VLDL- triglyceride secretion during prolonged hyperglyce- mia/hyperinsulinaemia in normal man[J]. J Clin Invest, 1996, 98:2 008-2 017.
  • 3Jalilian AR, Akhlaghi M, Mirzaii M, et al. Pro- duction and biological evaluation of [18 F]-6-thia- 14-fluoro-heptadecanoie acid [J].Nucl Med Rev Cent East Eur, 2006,9(2): 108-113.
  • 4Takala TO, Nuutila P, Pulkki K, et al. 14(R,S) [18F] Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardi- um and skeletal muscle[J]. Eur J Nucl Med Mol Imaging, 2002, 29(12): 1 617-1 622.
  • 5Guiducci L, Gronroos T, Jarvisalo MJ, et al. Bio- distribution of the fatty acid analogue 18 F FTHA : plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemia[J].J Nucl Med, 2007, 48(3): 455-462.
  • 6DeGrado TR, Kitapci MT, Wang S, et al. Valida- tion of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hy- poxia and composition of exogenous fatty acids[J]. J Nucl Med, 2006, 47(1):173-181.
  • 7DeGrado TR, Bhattacharyya F, Pandey MK, et al. Synthesis and preliminary evaluation of 18 (18) F-fluoro 4-thia-oleate as a PET probe of fatty acid oxidation[J]. J Nucl Med, 2010, 51(8): 1 310-1 317.
  • 8Stone CK, Pooley RA, DeGrado TR, et al. Myo- cardial uptake of the fatty acid analog 14-fluorine 18-fluoro-6 thia-heptadecanoie acid in comparison to beta-oxidation rates by tritiated palmitate[J].J Nucl Med, 1998, 39(10): 1 690-1 696.
  • 9Schulz G, von DJ, Kaiser H J, et al. Imaging of beta-oxidation by static PET with 14 (R, S)-[18 F] fluoro-6-thiaheptadecanoic acid (FTHA) in pa- tients with advanced coronary heart disease: a comparison with 18SFDG-PET and 99Tcm-MIBI SPET[J]. Nucl Med Commun, 1996, 17(12): 1 057-1 064.
  • 10Taylor M, Wallhaus TR, Degrado TR, et al. An evaluation of myocardial fatty acid and glucose up- take using PET with [18 F] fluoro-6-thia-heptade- canoic acid and [18 F]FDG in Patients with Conges- tive Heart Failure[J]. J NuclMed, 2001, 42(1): 55 62.

同被引文献16

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部